In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...

Key Takeaways The S&P 500 fell 1.6% on Tuesday, April 8, 2025, as investors braced for new tariffs to take effect.Albemarle shares tumbled after UBS cut its price target on the lithium producer's ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P 500, bagged a ... look at the sector’s performance and where its ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the just-concluded quarter ...

We're nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite recent volatility stemming from tariff talks and other economic ...

Year to date, the S&P 500 is now down nearly 4.5%, and many investors are worried that there could be further declines coming. The best-performing stock on this list is CVS Health, which has risen ...

Market sentiment remained cautious, with investors also digesting corporate earnings from CVS Health and watching Tesla’s ongoing selloff. At 13:14 GMT, S&P 500 futures edged up 0.08% ...

And concerning the all-star performers, Philip Morris PM, CVS Health CVS, and Newmont NEM all reflect top-performing S&P 500 stocks ... the stock’s strong YTD performance, up nearly 30%.

In the most recent trading session, CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the ...